The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Agree with both those posts Tommy, all of it, this is a big blip, and I do still believe 2024 revenues will be the start of a well overdue upshift. You are right these guys are utterly useless as putting out announcements.. Beyond frustrating
This is a very positive and responsible and pro active step by the affiliates
https://www.prnewswire.com/news-releases/gambling-affiliates-create-new-group-to-protect-consumers-responsible-gambling-affiliate-association-rgaa-or-the-group-or-the-association-301980842.html?tc=eml_cleartime
Agree Box wildly undervalued. In fact all 250 and small caps now at 3 year lows, sell off nearly done imo. Buying FTSE 250 quite widely and select small caps aggressively next 3-6 months. XL will be back 2024, hold tight
Barchid there was a big article on this stock in SCSW, a very well respected publication. Worth the subscription imo. I got in after reading the article and have added since. This one has a bright future. DYOR before buying, but SCSW worth a look
Box this is wildly undervalued. Fair value even in this crappy market is about 20p plus imo. The optics are bad this year due to the massive spike in revenue in 2022 (NY opening), this means 2023 revenue will be down on 2022 but up on 21, any serious investor should not lose sight of that. This should start coming good once all the small caps stop selling off. Going to be a challenging rest of the year though I'm afraid, we need the geo political environment to get resolved.
Oh and picked ignore the poster 'oldboydumdum', this is John09 from ADVFN. He is a notorious stalker obsessed with me and a few others that challenge him. He is a known troll. He is a seriously unhinged individual known to most posters in the community.
Https://bookies.com/news/kentucky-sports-betting-online-sportsbook-wagering
Picked its badly oversold. AIM stocks have been hot incredibly badly. The index is incredibly low at the moment and at similar levels to the COViD crash. Look at the 5 year chart. I would put a fair price at around 20p. Patience needed i’m afraid.
Also just listened to the webcast H1 2022 is an absolute outlier and very significant high one off episodic revenue for the reasons they stated and won’t be repeated imminently. We should look at 2021 FY. If 2023 FY exceeds 2021 FY the business will prove to be trending in the right direction. All indicators suggest it will. Then 2024 needs to exceed 2023 FY and I truly believe it will again on the metrics provided and reengineering work done. One needs to have run a business with unsettling and rare episodic revenue spikes that can’t be repeated the following financial year to truly understand this. I have it’s a nightmare as optically looks bad at first glance. Meeting the pay outs in 2024 will be a strain however but again think this will be largely another episodic event. I truly believe 2023 FY numbers will exceed 21 and believe 2024 will exceed 23. 2022 will become an outlier year. Not concerned for the LONG term.
Made me chuckle too cheers Tommy 😂 Peaky you are 100% spot on and this is what the analysts are saying too. They are now perfectly positioned for real YOY growth. And also it’s not just XLm that have taken a dive and now oversold. Loads came off a high peak of the Covid time. Reach and Luceco prime examples . There are dozens I could mention . A lot small caps oversold and this will swing back
Absolutely spot on Pompal . This guy is obsessed with me and XLM. He’s been posting on them for 3 years on ADVFN first claiming he holds a million shares ( his go to number also saying he holds a million of this and that all usually SCSW reconditions) and then days he has no XLM shares and continues to post. On ADVFN he has also set up multiple profiles to back all his statements and talks to himself through these multiple profiles as no one else takes him seriously . I’ve never seen anything like this
This latest from Research XLMedia continue to make good progress in refocusing the business, and the outlook remains positive for state openings and the new NFL season. We maintain our FY23 forecasts for Adj EBITDA and Adj PAT targets at $16m and $7.9m respectively. We expect them to be achieved with lower revenue and lower costs given a higher margin revenue mix and lower OpEx. XLM looks compelling on an FY1 EV/EBITDA multiple of 1.4x vs peers on 5.4x, and we iterate a 1-year price target of 29p